About ono pharm - OPHLY
Ono Pharmaceutical Co., Ltd. engages in the production, purchase, and sale of internal medicine, patch and injectable medicine. The company was founded by Ichibei Fushimiya in 1717 and is headquartered in Osaka, Japan.
OPHLY At a Glance
Ono Pharmaceutical Co., Ltd.
1-8-2 Kyutaromachi
Osaka, Osaka 541-8564
| Phone | 81-6-6263-5670 | Revenue | 3.19B | |
| Industry | Pharmaceuticals: Major | Net Income | 328.28M | |
| Sector | Health Technology | Employees | 4,287 | |
| Fiscal Year-end | 03 / 2026 | |||
| View SEC Filings |
OPHLY Valuation
| P/E Current | 17.636 |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | 15.33 |
| Price to Sales Ratio | 1.576 |
| Price to Book Ratio | 0.962 |
| Price to Cash Flow Ratio | 9.31 |
| Enterprise Value to EBITDA | 7.847 |
| Enterprise Value to Sales | 1.455 |
| Total Debt to Enterprise Value | 0.211 |
OPHLY Efficiency
| Revenue/Employee | 744,958.277 |
| Income Per Employee | 76,576.602 |
| Receivables Turnover | 3.436 |
| Total Asset Turnover | 0.486 |
OPHLY Liquidity
| Current Ratio | 3.069 |
| Quick Ratio | 2.564 |
| Cash Ratio | 1.419 |
OPHLY Profitability
| Gross Margin | 68.903 |
| Operating Margin | 13.019 |
| Pretax Margin | 12.16 |
| Net Margin | 10.279 |
| Return on Assets | 4.992 |
| Return on Equity | 6.27 |
| Return on Total Capital | 5.284 |
| Return on Invested Capital | 5.824 |
OPHLY Capital Structure
| Total Debt to Total Equity | 18.746 |
| Total Debt to Total Capital | 15.787 |
| Total Debt to Total Assets | 13.785 |
| Long-Term Debt to Equity | 14.506 |
| Long-Term Debt to Total Capital | 12.216 |